Occipital Lobe to Femoral Blood Ratios of Amphetamine, Methamphetamine, Cocaine, Benzoylecgonine, Cocaethylene, and Fentanyl in Postmortem Cases
Clicks: 9
ID: 322006
2026
Article Quality & Performance Metrics
Overall Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
0.0
/100
0 views
0 readers
AI Quality Assessment
Not analyzed
Abstract
Abstract Interpretation of postmortem toxicology results is complicated by postmortem redistribution (PMR), which can alter drug concentrations between tissues and blood (BL). This study evaluates brain (BR) to BL concentration ratios for amphetamine (AMP), methamphetamine (MAMP), cocaine (COC), benzoylecgonine (BE), cocaethylene (CE), and fentanyl (FENT) using postmortem casework data to evaluate the utility of BR tissue as an alternative matrix. BR:BL ratios varied widely across analytes: AMP (2.2–5.8), BE (0.2–2.1), CE (1.2–5.1), COC (0.1–5.8), MAMP (2.2–7.3), and FENT (1.1–24.8). Lipophilic compounds (AMP, CE, COC, MAMP, FENT) generally exhibited ratios greater than one, consistent with preferential BR partitioning and susceptibility to PMR, whereas the polar metabolite BE showed ratios less than one, reflecting limited BR accumulation. FENT demonstrated the greatest variability, highlighting challenges in interpreting its postmortem concentrations. Correlations between BR and femoral BL concentrations were slightly positive for all analytes, indicating that BR concentrations may not be reliable proxies for BL levels. Evaluation of select antemortem cases and outliers revealed additional influences on BR:BL ratios, including survival time, drug stability, route of administration, and polysubstance use. COC instability and hydrolysis to BE, as well as incomplete drug distribution in rapid deaths, contributed to atypical ratios. Overall, BR:BL ratios are highly analyte dependent and influenced by both pharmacokinetic properties and postmortem factors. While BR tissue may provide useful complementary information when BL is unavailable, it should not be used as a direct substitute for BL in toxicological interpretation. These findings underscore the need for further research to expand BR:BL datasets across drug classes.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (250 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7170036232
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Grayce Behnke, Teresa R Gray |
| Journal | journal of analytical toxicology |
| Year | 2026 |
| DOI |
10.1093/jat/bkag068
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.